EcoDrugPlus

Ensembl ID : ENSNBRG00000000445
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSNBRG00000018427
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSNBRG00000000427
Gene Symbol: -
Cross references: -
4 Possible Orthologues:

Ensembl ID : ENSNBRG00000011006
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSNBRG00000016011
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSNBRG00000014525
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSNBRG00000018347
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSNBRG00000014497
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSNBRG00000014417
Gene Symbol: -
Cross references: -
386 Possible Orthologues:

Ensembl ID : ENSNBRG00000002561
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSNBRG00000001739
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSNBRG00000013997
Gene Symbol: -
Cross references: -
177 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).